434 related articles for article (PubMed ID: 27382281)
1. A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements.
Giannakou C; Park MV; de Jong WH; van Loveren H; Vandebriel RJ; Geertsma RE
Int J Nanomedicine; 2016; 11():2935-52. PubMed ID: 27382281
[TBL] [Abstract][Full Text] [Related]
2. Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls.
Giannakou C; Park MVDZ; Bosselaers IEM; de Jong WH; van der Laan JW; van Loveren H; Vandebriel RJ; Geertsma RE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1633. PubMed ID: 32266791
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicinal products: a survey on specific toxicity and side effects.
Brand W; Noorlander CW; Giannakou C; De Jong WH; Kooi MW; Park MV; Vandebriel RJ; Bosselaers IE; Scholl JH; Geertsma RE
Int J Nanomedicine; 2017; 12():6107-6129. PubMed ID: 28883724
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two guidelines on immunotoxicity testing of medicinal products.
Dujmović IH
Arh Hig Rada Toksikol; 2005 Sep; 56(3):265-8. PubMed ID: 16180612
[TBL] [Abstract][Full Text] [Related]
5. Regulatory aspects of immunotoxicology.
Schulte A; Ruehl-Fehlert C
Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
[TBL] [Abstract][Full Text] [Related]
6. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
Spanhaak S
Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
[TBL] [Abstract][Full Text] [Related]
7. Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies.
Urbán P; Liptrott NJ; Bremer S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1546. PubMed ID: 30556649
[TBL] [Abstract][Full Text] [Related]
8. Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?
Dusinska M; Tulinska J; El Yamani N; Kuricova M; Liskova A; Rollerova E; Rundén-Pran E; Smolkova B
Food Chem Toxicol; 2017 Nov; 109(Pt 1):797-811. PubMed ID: 28847762
[TBL] [Abstract][Full Text] [Related]
9. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
[TBL] [Abstract][Full Text] [Related]
10. Report of validation study of assessment of direct immunotoxicity in the rat. The ICICIS Group Investigators. International Collaborative Immunotoxicity Study.
Toxicology; 1998 Feb; 125(2-3):183-201. PubMed ID: 9570332
[TBL] [Abstract][Full Text] [Related]
11. The accuracy of extended histopathology to detect immunotoxic chemicals.
Germolec DR; Kashon M; Nyska A; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
Toxicol Sci; 2004 Dec; 82(2):504-14. PubMed ID: 15342959
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxicology: role in the safety assessment of drugs.
Descotes J
Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
[TBL] [Abstract][Full Text] [Related]
13. Early detection of immunotoxicity: from animal studies to human biomonitoring.
Van Loveren H; Steerenberg PA; Vos JG
Toxicol Lett; 1995 May; 77(1-3):73-80. PubMed ID: 7618171
[TBL] [Abstract][Full Text] [Related]
14. Assessing immunotoxicity: guidelines.
Putman E; van der Laan JW; van Loveren H
Fundam Clin Pharmacol; 2003 Oct; 17(5):615-26. PubMed ID: 14703723
[TBL] [Abstract][Full Text] [Related]
15. From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system.
Smith MJ; Brown JM; Zamboni WC; Walker NJ
Toxicol Sci; 2014 Apr; 138(2):249-55. PubMed ID: 24431216
[TBL] [Abstract][Full Text] [Related]
16. Target organs and systems: methodologies to assess immune system function.
Karol MH
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):533-40. PubMed ID: 9599701
[TBL] [Abstract][Full Text] [Related]
17. Cytokines as biomarkers of nanoparticle immunotoxicity.
Elsabahy M; Wooley KL
Chem Soc Rev; 2013 Jun; 42(12):5552-76. PubMed ID: 23549679
[TBL] [Abstract][Full Text] [Related]
18. Are pesticides immunotoxic?
Botham PA
Adverse Drug React Acute Poisoning Rev; 1990; 9(2):91-101. PubMed ID: 2220474
[TBL] [Abstract][Full Text] [Related]
19. US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins.
Hinton DM
Toxicol Pathol; 2000; 28(3):467-78. PubMed ID: 10862567
[TBL] [Abstract][Full Text] [Related]
20. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
